# Xellia Pharmaceuticals USA LLC, Bedford, OH – FDA Inspections

Source: https://www.keypedia.com/companies/xellia-pharmaceuticals-usa-llc/a3a2eda2-040c-4cb8-8df0-2dd3fb12332f

> Inspection records and compliance data for Xellia Pharmaceuticals USA LLC in Bedford, Ohio. 5 FDA inspections on record, 1 Form 483, last inspected September 29, 2023.

---

## Details

- Name: Xellia Pharmaceuticals USA LLC
- FEI Number: 3012279857
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 200 Northfield Rd
- City: Bedford
- State: Ohio
- Zip Code: 44146
- Country Name: United States
- Address: 200 Northfield Rd, Bedford, Ohio 44146, United States
- Country: United States

## Related Documents

- [483 - Xellia Pharmaceuticals USA LLC - 2023-09-29](https://www.keypedia.com/records/483/xellia-pharmaceuticals-usa-llc/93d44f5f-72c1-46b2-a9d2-b59938687b28) — source: FDA, date: September 29, 2023
- [FDA Inspection 1220071 - Xellia Pharmaceuticals USA LLC - 2023-09-29](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8d9b38c-a723-4609-9dd4-0b9f92e5c364) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2023
- [483 - Xellia Pharmaceuticals USA LLC - 2022-12-15](https://www.keypedia.com/records/483/xellia-pharmaceuticals-usa-llc/fb9c3922-3ea2-46e3-b56c-84b4eb9e352d) — source: FDA, date: December 15, 2022
- FDA Inspection 1194565 - Xellia Pharmaceuticals USA LLC - 2022-12-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2022
- [483 - Xellia Pharmaceuticals USA LLC - 2022-02-07](https://www.keypedia.com/records/483/xellia-pharmaceuticals-usa-llc/2f5255cd-c4f9-46a6-aad5-f2c327bae925) — source: FDA, date: February 7, 2022
- [FDA Inspection 1161837 - Xellia Pharmaceuticals USA LLC - 2022-02-07](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d429f017-a9d2-407b-a75e-05a5eb33faa5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2022
- [EIR - Xellia Pharmaceuticals USA LLC - 2020-01-31](https://www.keypedia.com/records/eir/xellia-pharmaceuticals-usa-llc/b90435f2-1f34-4a7a-90d7-4846d1cd71b9) — source: FDA, date: January 31, 2020
- FDA Inspection 1117006 - Xellia Pharmaceuticals USA LLC - 2020-01-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2020
- [EIR - Xellia Pharmaceuticals USA LLC - 2016-10-13](https://www.keypedia.com/records/eir/xellia-pharmaceuticals-usa-llc/fd03b6e7-8634-4aaa-bb44-02e26e34e0bc) — source: FDA, date: October 13, 2016
- [FDA Inspection 990058 - Xellia Pharmaceuticals USA LLC - 2016-10-13](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8709417-c6c0-4b50-9435-3d7c749a5d34) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2016

## Related Companies

- [Steven D. Folkerth, M.D.](https://www.keypedia.com/companies/steven-d-folkerth-md/3164acca-4fbc-4a78-b2c9-68a31e60fc72)
- [Oasis Consumer Healthcare, LLC](https://www.keypedia.com/companies/oasis-consumer-healthcare-llc/2ffab37a-f58e-4283-a724-2c3b663d4056)
- [Muhammad Salman Ali Ashraf](https://www.keypedia.com/companies/muhammad-salman-ali-ashraf/ab6eb8e0-e6a4-4016-8806-55e576621f2a)
- [Emily K. Curran, M.D.](https://www.keypedia.com/companies/emily-k-curran-md/0cc20197-744b-40f7-86a7-9d71d8401047)
- [Jessica Kaffenberger, M.D.](https://www.keypedia.com/companies/jessica-kaffenberger-md/39a0b196-5ffd-4456-b43e-baa2e2a99152)
- [John Hays](https://www.keypedia.com/companies/john-hays/3081ff46-11c3-4a1d-8ff1-5b6ec4545f4b)
- [Martin T. Taylor, DO, PhD](https://www.keypedia.com/companies/martin-t-taylor-do-phd/69488d56-0ece-439d-ad0d-8db7beceea47)
- [James N Allen MD](https://www.keypedia.com/companies/james-n-allen-md/1ca0a469-bdd0-4599-9d12-403cba42ef9b)
- [Exel Inc.](https://www.keypedia.com/companies/exel-inc/56c103aa-f156-4cde-abd5-c1e6fcc34860)
- [Sameek Roychowdhury, MD](https://www.keypedia.com/companies/sameek-roychowdhury-md/83ca1e41-4bf5-418e-b31c-91e64600c772)

## Related Officers

- [Nicholas L. Paulin](https://www.keypedia.com/people/nicholas-l-paulin/a8e0649a-614f-499b-8fdc-1217f7d71887)
- [Investigator ](https://www.keypedia.com/people/lindsey-schwierjohann/3608e7c0-5bb9-49f0-844d-ddd6f6724fdb)
- [company_representative](https://www.keypedia.com/people/jamie-iudica/43912116-ca96-42df-831c-9609798a8e87)
- [Drug Specialist](https://www.keypedia.com/people/lauren-n-howard/538f77fe-b977-49c9-a5b3-289cf8a6e886)
- [Andrew J. Barrowcliff](https://www.keypedia.com/people/andrew-j-barrowcliff/5dd49407-9028-4c84-9e86-3f0b6239538e)
- [Consumer Safety Officer , Investigator](https://www.keypedia.com/people/lisa-r-hilliard/611735cf-5c20-424c-801a-03888d8d1b0a)
